immunosuppressants for crohn’s disease

Immunosuppressants remain cornerstone treatments for moderate-to-severe Crohn’s disease, yet their promise comes wrapped in complexity. While azathioprine and methotrexate suppress immune attacks that damage your colon, they simultaneously reduce your body’s ability to fight infections and may require monthly blood monitoring. In 2026, patients increasingly weigh conventional immune suppression against targeted botanical therapies that address